The Patent Finder

MacKay Memorial Hospital

28 patents currently held · Updated Nov 21, 2026
6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

1
Ending by 2030
Jun 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Dec 4 to 9, 2026 · next Dec 4
  • 1 fee due Jan 4, 2027
    The maintenance fee for Formulation comprising extracellular vesicles, method for producing the same, and uses thereof (US 11,692,172) comes due Jan 4, 2027. Unpaid by Jul 6, 2027, it lapses early.
  • 1 fee due Feb 11, 2027
    The maintenance fee for Use of Gold Nanoclusters in Ameliorating Oxidate Stress And/Or Aging (US 9,101,672) comes due Feb 11, 2027. Unpaid by Aug 11, 2027, it lapses early.
  • 3 fees due May 5 to 19, 2027 · next May 5
  • 1 fee due Sep 26, 2027
    The maintenance fee for Respiratory mask (US 11,938,272) comes due Sep 26, 2027. Unpaid by Mar 27, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,994,158Method for inhibiting tumor growth with dehydrosulphurenic acid extracted from Antrodia cinnamomea
In force
 · USPTO record
In forceUSPTO record
US 8,507,446Use of PEDF-derived polypeptides for treating liver cirrhosis
In force
 · USPTO record
In forceUSPTO record
US 9,617,311Use of PEDF-derived polypeptides for promoting stem cells proliferation and wound healing
In force
 · USPTO record
In forceUSPTO record
US 9,884,012Use of Pedf-Derived Polypeptides for Promoting Muscle or Tendon Regeneration or Arteriogenesis
In force
 · High confidence
In forceHigh confidence
US 9,938,328Use of Pedf-Derived Polypeptides for Treating Alopecia And/Or Hair Depigmentation
In force
 · High confidence
In forceHigh confidence
US 9,815,878Use of Pedf-Derived Polypeptides for Preventing And/Or Ameliorating Skin Aging
In force
 · High confidence
In forceHigh confidence
US 9,777,048Use of Pedf-Derived Polypeptides for Treating Osteoarthritis
In force
 · High confidence
In forceHigh confidence
US 9,051,547Use of PEDF-derived polypeptides for promoting stem cells proliferation and wound healing
In force
 · USPTO record
In forceUSPTO record
US 9,101,672Use of Gold Nanoclusters in Ameliorating Oxidate Stress And/Or Aging
In force
 · High confidence
In forceHigh confidence
US 10,307,456Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
In force
 · USPTO record
In forceUSPTO record
10 of 28 patents shown.
Pro members see all 28.
Pro members: see all 28 patents
Also on record, not counted in the 28: 6 patents in force now held by others · 24 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 4 abandoned · 9 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited